Obesity in type 2 diabetes — local experience in a district general hospital

Abstract

Obesity, diabetes and glycaemic control are inter-linked. Weight gain is associated with worsening diabetic control and can be exacerbated by therapies aimed at controlling hyperglycaemia. Auditing our practice in a district general hospital, we have examined our diabetic population with regards to age and weight, HbA1C and body mass index (BMI), and for weight gain following conversion to insulin.

Keywords

obesity type 2 diabetes insulin.

Get full access to this article

View all access options for this article.

References

Tattersall RB , Gale EAM. Obesity and Diabetes in: Tattersall RB, Gale EAM , (ed.). Diabetes: Clinical Management. Churchill Livingstone (London), UK, 1990;16:185-91.

Life in the 21st century: A Vision for all. WHO, World Health Report, Geneva, 1998 .

Bourn J. Tackling obesity in England. National Audit Office , London, 2001.

Campbell IW , Purcell H. The silent sextet. Br J Diabetes Vasc Dis 2001; 1:3-6.

Manson JE , Willett WC , Stampfer MJ et al. Body weight and mortality among women. N Engl J Med 1995;333:677-85.

Chinn S. , Rona R. Prevalence and trends in overweight and obesity in three cross sectional studies in British children, 1974-94. BMJ 2001;322: 24-6.

Campbell K. , Waters E. , O'Meara S. et al. Interventions for preventing obesity in children (Cochrane Review). Issue 1. The Cochrane Library, Oxford: Update Software, 2003.

Pinkney J. Implications of obesity for diabetes and coronary heart disease in clinical practice. Br J Diabetes Vasc Dis 2001;1:103-06.

Tattersall R. Diseases the doctor (or auto analyser) says you have got. Clin Med JRCPL 2001;1:230-3.

10.

Andel M. , Tattersall R. Authoritarianism in Diabetology. Diabet Med 1989;6:471.

11.

Leslie P. , Jung RT , Isles TE et al. Effect of optimal glycaemic control with continuous subcutaneous insulin infusion on energy expenditure in type 1 diabetes mellitus. BMJ 1986;293:1121-6.

12.

Genuth S. Insulin use in NIDDM. Diabetes Care 1990;13:1240-64.

13.

Gardner SG , Dunuchie S. , Levy JC Audit of initiation of insulin treatment in type 2 diabetes. Diabet Med 2002;19:187.

14.

Moleele GT , Marshall J. , Mansell P.

At what level do patients with type 2 diabetes benefit from insulin?

Diabet Med 2002;19:188.

15.

Cavan DA , Perrott T. , Kerr D. Towards the paperless diabetes centre. Diabet Med 2001;18:101.

16.

Campbell L. , Rossner S. Management of obesity in patients with type 2 diabetes. Diabet Med 2001;18:345-54.

17.

Pugh JA , Wagner ML , Sawyer J. et al. Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A meta-analysis. Diabetes Care 1992 ;15:953-9.

18.

Sane T. , Helve E. , Yki-jarvinen H. et al. One-year response to evening insulin therapy in non-insulin-dependent diabetes. J Intern Med 1992;231:253-60.

19.

Flanagan DE , Holt H. , Thomas P. et al. The clinical reality of switching to insulin in type 2 diabetes . Unpublished data.

20.

Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin . N Engl J Med 2002;346:393-403.

21.

Toumilehto J. , Lindstrom J. , Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.

22.

Dunea G. Clients on diets. BMJ 2001;323:1435.